GHKCU, CJ, TR, purity 99% US, UK, Chinese peptide factory, rapid deliv RT, KLOW ,GLOW ,TB500 Jack
146 Inquiries
49557-75-7
ep
99%
HongKong
HUATAI
10 vials
2026-11-02
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionChEBI: Gly-His-Lys is a tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence. It has a role as a metabolite, a chelator, a vulnerary and a hepatoprotective agent.Basic Info
-
Product Name:
Copper Peptide
Other Name:GHK Cu Copper Peptide;L-Lysine,glycyl-L-histidyl-;Copper Peptide powder (GHK-cu);GHK Cu Copper Peptide GHK.Cu GHK-Cu;Liver Cell Growth Factor(GHK);GHKcu/Growth-Modulating peptide;(Gly-His-Lys)2Cu.xHAc;AHK-Cu (Copper Peptide)
CAS No.:49557-75-7
Molecular Formula:C14H24N6O4
InChIKeys:MVORZMQFXBLMHM-QWRGUYRKSA-N
Molecular Weight:340.38
EC Number:1592732-453-0
Color/Form:Off-White
Categories:
Characteristics-
Density:
1.324
Melting Point:>144°C (dec.)
Boiling Point:831.0±65.0 °C(Predicted)
PKA:3.11±0.10(Predicted)
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
Actin-sequestering protein / 43-amino-acid peptide
Status:Research compound — Not FDA approved (investigational: RGN-259 for dry eye / neurotrophic keratitis)
Mechanism:A naturally occurring 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) that binds G-actin (sequesters monomeric actin), preventing F-actin polymerization. Promotes cell migration, angiogenesis, wound healing, and anti-inflammatory responses via integrin-linked kinase (ILK) and HIF-1α/VEGF pathways. TB-500 is the synthetic fragment Ac-LKKTETQ (MW ~895) often sold under this CAS.
Activity note:Thymosin Beta-4 is an actin-binding protein, not a receptor agonist. Functional activity is measured by actin sequestration (Kd ~0.7–1 μM) and cell migration assays, not EC₅₀.
Source:Goldstein AL, et al. Vitam Horm. 2003;66:257–296. RegeneRx RGN-259 clinical program.DOI
Clinical Development:
References-
DrugBank:PubChem:UNII:Disclaimer:
Thymosin Beta-4 (TB-500) is NOT FDA-approved for human therapeutic use. RGN-259 (Tβ4 ophthalmic solution) is an investigational drug not yet approved. TB-500 sold on research-chemical marketplaces is a synthetic fragment and is not an approved medicine. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Location:
1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA
-
-
Inquiry History146 Inquiries
Country Product Purchase Quantity Date Posted
United States
Cosmetic Copper GhkCU Peptide CAS 49557-75-7 Peptide 50mg Ghk-Cu
2 MT Nov 6, 2023
Malaysia
High quality 98% up Copper Peptide GHK-Cu powder CAS 49557-75-7
1 KG Oct 19, 2023
United States
Copper Peptide 99% Copper Peptide Ghk-Cu Powder Ghk Cu CAS 49557-75-7
1 KG Mar 26, 2026
China
Glycyl-l-histidyl-l-lysine
10 KG Oct 24, 2023
Sweden
GHK-Cu
1 KG Mar 17, 2026
China
Ghk-Cu
1 MT Aug 6, 2026
United Kingdom
ghk-cu
100 MG Jul 23, 2026
Brazil
Ghk-cu
30 MG Jul 14, 2026
United States
GHK-Cu
100 MG Jul 13, 2026
United States
GHK-Cu
1 G Jul 13, 2026
United States
GHK-CU
5 MT Jul 12, 2026
Brazil
GHK-Cu
50 MG Jul 9, 2026
United States
Ghost-cu
200 MT Jul 6, 2026
United Kingdom
GHK-cu
50 MG Jul 3, 2026
United States
Cooper peptide
1 G Jun 30, 2026
South Africa
GHK-CU
3 MG Jun 17, 2026
United States
GHK-CU
1 MT Jun 13, 2026
Canada
Ghk-cu
500 MG Jun 11, 2026
Australia
GHK-Cu
1 G Jun 8, 2026
United States
GHK-CU
10 MT Jun 5, 2026 Post an enquiry for this product